[Specific therapy of extrapyramidal-motor syndromes].
D000700:Analgesics / Q000627:therapeutic use; D001264:Athetosis / Q000628:therapy*; D002819:Chorea / Q000628:therapy*; D013286:Datura stramonium / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004422:Dystonia Musculorum Deformans / Q000628:therapy*; D005116:Extrapyramidal Tracts; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000628:therapy; D008750:Methyldopa / Q000627:therapeutic use; D009069:Movement Disorders / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D009207:Myoclonus / Q000628:therapy*; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000628:therapy*; D010301:Parkinson Disease, Postencephalitic / Q000628:therapy; D010640:Phenothiazines / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011247:Pregnancy; D011736:Pyridoxine / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D012601:Scopolamine / Q000627:therapeutic use; D013238:Stereotaxic Techniques; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000700:Analgesics; D010276:Parasympatholytics; D010640:Phenothiazines; D014149:Tranquilizing Agents; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D012601:Scopolamine; D011736:Pyridoxine
Die spezielle Therapie der extrapyramidal-motorischen Syndrome.